Skip to main content

Table 4 GIPAP: Results of a Random Effects Ordered Probit Model

From: Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

Dependent Variable

Curphase

 

Odds Ratio

SE

Quarter

1.071***

0.004

Origphase

30.508***

0.036

Ins

0.989

0.062

Ageatapproval

0.999

0.001

Gender

1.050

0.036

Gap

0.995***

0.002

Close

0.652***

0.039

Argentina

3.561***

0.206

Chile

1.018

0.201

China

1.081

0.098

El Salvador

0.819

0.220

Georgia

2.773***

0.260

India

1.182

0.098

Kenya

0.285***

0.263

Malaysia

1.605**

0.187

Mexico

0.880

0.120

Nigeria

0.619*

0.263

Pakistan

0.839

0.109

Russia

0.832

0.154

South Africa

1.010

0.144

Sudan

13.237***

0.202

Undefined

2.179***

0.153

Business

1.394***

0.086

Education

1.330*

0.124

Government

1.259*

0.100

Health-Social

0.931

0.130

Hospitality

1.266

0.177

Manufacturing

1.081

0.079

Other

0.984

0.050

Retired

1.085

0.100

Self Employed

1.247***

0.068

Student

1.181*

0.094

Transport

1.269

0.221

Unemployed

1.112

0.065

Log Likelihood

-19792.852

LR chi2(31)

9836.92

Observations

66,681

  1. Note: Significance levels: *** indicates significance at 1% level; ** at 5% level and * at 10% level